Ensign Peak Advisors, Inc Collegium Pharmaceutical, Inc Transaction History
Ensign Peak Advisors, Inc
- $56.1 Billion
- Q3 2024
A detailed history of Ensign Peak Advisors, Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 21,943 shares of COLL stock, worth $628,008. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,943
Previous 21,943
-0.0%
Holding current value
$628,008
Previous $706,000
19.97%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding COLL
# of Institutions
253Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$166 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$75.4 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$74.1 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$67.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$47.4 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $977M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...